Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
AIDS ; 9(3): 235-42, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7755911

RESUMEN

OBJECTIVE: Maternal antibodies from either vaccinated or feline immunodeficiency virus (FIV)-infected female cats (queens) were evaluated for their ability to protect kittens against homologous FIV infection. DESIGN: Kittens that received different levels of maternal antiviral antibodies from either vaccinated or infected queens were inoculated with homologous FIV at 1 week post-parturition and monitored for FIV infection. Maternal antiviral antibodies in the kittens were also measured and compared to the level of FIV infection. METHODS: Kittens at 1 week post-parturition were inoculated intraperitoneally with five median cat infectious doses of FIVPet. FIV infection was monitored by virus isolation for infectious FIV and by nested polymerase chain reaction for proviral DNA. Virus-neutralizing (VN) antibodies and antibodies to FIV transmembrane peptide and core protein were also monitored throughout the 25 weeks. RESULTS: Neonatal kittens that received high levels of antiviral antibodies from either vaccinated or infected queens were protected from FIV inoculation. Kittens that received low levels of maternal antiviral antibodies were not completely protected from similar FIV inoculation. Protection correlated more closely with the level of maternal VN antibodies than the anti-p25 antibodies transferred to the kittens. The unprotected kittens born to infected queens were not infected from vertical transmission because all littermates that were not FIV-inoculated remained free of FIV infection. CONCLUSIONS: Maternal antiviral antibodies, including VN antibodies, from either vaccinated or infected queens protected neonatal kittens from FIV inoculation. Thus, maternal antiviral antibodies play a key role in preventing or limiting infection in neonates and such antiviral immunity can be provided by vaccinated queens.


Asunto(s)
Inmunidad Materno-Adquirida , Virus de la Inmunodeficiencia Felina/inmunología , Infecciones por Lentivirus/prevención & control , Animales , Animales Recién Nacidos , Anticuerpos Antivirales/sangre , Secuencia de Bases , Gatos , ADN Viral/sangre , Femenino , Virus de la Inmunodeficiencia Felina/aislamiento & purificación , Transmisión Vertical de Enfermedad Infecciosa , Infecciones por Lentivirus/transmisión , Datos de Secuencia Molecular , Pruebas de Neutralización , Organismos Libres de Patógenos Específicos , Vacunación , Proteínas Virales/inmunología , Vacunas Virales/inmunología
2.
J Foot Ankle Surg ; 34(2): 153-62, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7599613

RESUMEN

The authors describe a new surgical technique for the correction of metatarsus adductus using an abductory osteotomy performed in the lesser tarsal region that enables transverse plane correction of an adducted forefoot. This procedure is based on the premise that matatarsus adductus deformity is actually a deformity of the midtarsus rather than the metatarsus segment of the foot. The osteotomy technique involves shortening of the lateral column using closing wedge technique and lengthening of the medial column using opening wedge technique. The correction is entirely in the transverse plane; however, modifications may be performed when other planal deformities are present. Historical review, principles, technique, and case studies are discussed.


Asunto(s)
Deformidades Congénitas del Pie/cirugía , Metatarso/anomalías , Metatarso/cirugía , Osteotomía/métodos , Trasplante Óseo , Preescolar , Contraindicaciones , Disección/métodos , Pie Plano/complicaciones , Pie Plano/cirugía , Deformidades Congénitas del Pie/complicaciones , Deformidades Congénitas del Pie/diagnóstico por imagen , Humanos , Lactante , Osteotomía/efectos adversos , Radiografía , Trasplante Autólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...